Expression of acetylcholine in lymphocytes and modulation of an independent lymphocytic cholinergic activity by immunological stimulation

Biogenic Amines

Volumn 17, Issue 4-6, 2003, Pages 373-386

  Fujii, Takeshi ^a   Watanabe, Yoshihiro ^a   Fujimoto, Kazuko ^a   Kawashima, Koichiro ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

Acetylcholine; CD4+ T cell; CD8+ T cell; Choline acetyltransferase; Muscarinic receptor; Nicotinic receptor

Indexed keywords

ACETYLCHOLINE; ACETYLCHOLINESTERASE; CALCIUM ION; CD11 ANTIGEN; CD4 ANTIGEN; CD7 ANTIGEN; CD8 ANTIGEN; CHOLINE ACETYLTRANSFERASE; CHOLINERGIC RECEPTOR; MESSENGER RNA; MONOCLONAL ANTIBODY; MUSCARINIC RECEPTOR; NICOTINIC RECEPTOR; NITRIC OXIDE; PHYTOHEMAGGLUTININ; PROTEIN C FOS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN BINDING; ARTICLE; CALCIUM CELL LEVEL; CHOLINERGIC ACTIVITY; CHOLINERGIC SYSTEM; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GENE EXPRESSION REGULATION; HELPER CELL; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOSTIMULATION; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPONTANEOUSLY HYPERTENSIVE RAT; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; UPREGULATION; WESTERN BLOTTING;

ANIMALIA; MAMMALIA;

EID: 0141481096     PISSN: 01688561     EISSN: None     Source Type: Journal    
DOI: 10.1163/15693910260698320     Document Type: Article

References (67)

1. Abo, T. and Kawamura, T. (2002). Immunomodulation by the autonomic nervous system: Therapeutic approach for cancer, collagen diseases, and inflammatory bowel diseases, Ther. Apher. 6, 348-357.
2. 3H-QNB binding to intact lymphocytes and lysed lymphocyte membranes, Life Sci. 38, 1359-1368.
3. Alexander, S. P. H., Mathie, A. and Peters, J. A. (2001). in: The 2001 Tips Nomenclature Supplement, 12th edn, pp. 6-12. Current Trends, London,
4. Ando, T., Fujii, T. and Kawashima, K. (1999). Expression of three acetylcholinesterase mRNAs in human lymphocytes, Jpn. J. Pharmacol. 79 (Suppl. I), 289P.
5. Berrard, S., Varoqui, H., Cervini, R., et al. (1995). Coregulation of two embedded gene products, choline acetyltransferase and the vesicular acetylcholine transporter, J. Neurochem. 65, 939-942.
6. Bock, H. A., Gallati, H., Zurcher, R. M., et al. (1995). A randomized prospective trial of prophylactic immunosuppression with ATG-fresenius versus OKT-3 after renal transplantation, Transplantation 59, 830-840.
7. Bonner, T. I., Buckley, N. J., Young, A. C., et al. (1987). Identification of a family of muscarinic acetylcholine receptor genes, Science 237, 527-532.
8. Bonner, T. I., Young, A. C., Brann, M. R., et al. (1988). Cloning and expression of the human and rat m5 muscarinic receptor genes, Neuron 1, 403-410.
9. Fujii, T. and Kawashima, K. (1999). Presence of two distinct intracellular calcium signaling pathways via muscarinic and nicotinic receptors in human T- and B-cell lines, Jpn. J. Pharmacol. 79 (Suppl. I), 287P.
10. 3 muscarinic acetylcholine receptors in human T- and B-cells, Jpn. J. Pharmacol. 84, 124-132.
11. 2+ oscillation and c-fos gene expression induced via muscarinic acetylcholine receptor in human leukemic T- and B-cell lines, Naunyn-Schmiedeberg's Arch. Pharmacol. 362, 14-21.
12. 2+ signaling and c-fos gene expression mediated via muscarinic receptors in human T-cells, Gen. Pharmacol. 35, 71-75.
13. Fujii, T. and Kawashima, K. (2001b). The non-neuronal cholinergic system: an independent, non-neuronal cholinergic system in lymphocytes, Jpn. J. Pharmacol. 85, 11-15.
14. Fujii, T. and Kawashima, K. (2001c). Activation of cholinergic system in T-lymphocytes by stimulation of CD11a molecule, Neurosci. Res. 25 (Suppl.), S147.
15. Fujii, T., Yamada, S., Misawa, H., et al. (1995a). Expression of choline acetyltransferase mRNA and protein in T-lymphocytes, Proc. Jpn. Acad. 71B, 231-235.
16. Fujii, T., Yamada, S., Yamaguchi, N., et al. (1995b). Species differences in the concentration of acetylcholine, a neurotransmitter, in the whole blood and plasma, Neurosci. Lett. 201, 207-210.
17. Fujii, T., Misawa, H. and Kawashma, K. (1996a). Induction of choline acetyltransferase mRNA in human T-lymphocytes during the immune responses, Neurosci. Res. 20 (Suppl.), S110.
18. Fujii, T., Tsuchiya, T., Yamada, S., et al. (1996b). Localization and synthesis of acetylcholine in human leukemic T cell lines, J. Neurosci. Res. 44, 66-72.
19. Fujii, T., Mori, Y., Tominaga, H., et al. (1997). Maintenance of constant acetylcholine content before and after feeding in young chimpanzees, Neurosci. Lett. 227, 21-24.
20. Fujii, T., Yamada, S., Watanabe, Y., et al. (1998). Induction of choline acetyltransferase mRNA in human mononuclear leukocytes stimulated by phytohemagglutinin, a T-cell activator, J. Neuroimmunol. 82, 101-107.
21. Fujii, T., Tajima, S., Yamada, S., et al. (1999). Constitutive expression of mRNA for the same choline acetyltransferase as that in the nervous system, an acetylcholine-synthesizing enzyme, in human leukemic T-cell lines, Neurosci. Lett. 259, 71-74.
22. Fujii, T., Ushiyama, N., Hosonuma, K., et al. (2002). Effects of human antithymocyte globulin on acetylcholine synthesis, its release and choline acetyltransferase transcription in a human leukemic T-cell line, J. Neuroimmunol. 128, 1-8.
23. Fujii, T., Okuda, T., Haga, T., et al. (2003a). Detection of the high-affinity choline transporter in the MOLT-3 human leukemic T-cell line, Life Sci. 72, 2131-2134.
24. 5 muscarinic acetylcholine receptor in human T- and B-lymphocytes during immunological responses, Neurochem. Res. 28, 423-429.
25. Fujimoto, K., Matsui, M., Fujii, T., et al. (2001). Decreased acetylcholine content and choline acetyltransferase mRNA expression in circulating mononuclear leukocytes and lymphoid organs of spontaneously hypertensive rat, Life Sci. 69, 1629-1638.
26. Fujimoto, K., Fujii, T. and Kawashima, K. (2003). Increased acetylchoine contents in blood and lymphoid organs of MRL/MpJ-lpr/lpr (MRL-lpr) mice, an immune accelerated model, J. Pharamacol. Sci. 91 (Suppl. I), 286.
27. Gordon, M. A., Cohen, J. J. and Wilson, I. B. (1978). Muscarinic cholinergic receptors in murine lymphocytes: demonstration by direct binding, Proc. Natl. Acad. Sci. USA 75, 2902-2904.
28. Grando, S., Kawashima, K. and Wessler, I. (2003). The non-neuronal cholinergic system in humans, Life Sci. 72, 2009-2012.
29. Horiuchi, Y., Kimura, R., Kato, N., et al. (2003). Evolutional study on acetylcholine expression, Life Sci. 72, 1745-1756.
30. Imboden, B. J., Shoback, M. D., Pattison, G., et al. (1986). Cholera toxin inhibits the T-cell antigen receptor-mediated increases in inositol trisphosphate and cytoplasmic free calcium, Proc. Natl. Acad. Sci. USA 83, 5673-5677.
31. Kamimura, Y., Fujii, T., Kojima, H., et al. (2003). Induction of nitric oxide (NO) synthase expression and NO production via muscarinic acetylcholine receptor-mediated pathways in the CEM human leukemic T-cell line, Life Sci. 72, 2151-2154.
32. Kapfhammer, J. and Bischoff, C. (1930). Acetylcholin und Cholin aus tierischen Organen, Z. Physiol. Chem. 191, 179-182.
33. Kawashima, K. and Fujii, T. (2000). Extraneuronal cholinergic system in lymphocytes, Pharmacol. Ther. 86, 29-48.
34. Kawashima, K. and Fujii, T. (2003). The lymphocytic cholinergic system in lymphocytes, Life Sci. 72, 2101-2109.
35. Kawashima, K., Ishikawa, H. and Mochizuki, M. (1980). Radioimmunoassay for acetylcholine in the rat brain, J. Pharmacol. Methods 3, 115-123.
36. Kawashima, K., Oohata, H., Fujimoto, K., et al. (1987). Plasma concentration of acetylcholine in young women, Neurosci. Lett. 80, 209-212.
37. Kawashima, K., Oohata, H., Suzuki, T., et al. (1989). Extraneuronal localization of acetylcholine and its release upon nicotine stimulation, Neurosci. Lett. 104, 336-339.
38. Kawashima, K., Kajiyama, K., Fujimoto, K., et al. (1993). Presence of acetylcholine in blood and its localization in circulating mononuclear leukocytes of humans, Biogenic Amines 9, 251-258.
39. Kawashima, K., Fujii, T., Misawa, H., et al. (1997). Presence of acetylcholine in the blood and its production by choline acetyltransferase in lymphocytes, in: Neurochemistry: Cellular, Molecular, and Clinical Aspects, Teelken, A. and Korf, J. (Eds), pp. 813-819. Plenum, New York.
40. Kawashima, K., Fujii, T., Watanabe, Y., et al. (1998). Acetylcholine synthesis and muscarinic receptor subtype mRNA expression in T-lymphocytes, Life Sci. 62, 1701-1705.
41. 2+ signaling and down-regulation of nicotinic acetylcholine receptor subunit gene expression in the CEM human leukemic T-cell line, Life Sci. 72, 2155-2158.
42. Maslinski, W. (1989). Cholinergic receptors of lymphocytes, Brain Behav. Immun. 3, 1-14.
43. Misawa, H., Takahashi, R. and Deguchi, T. (1995). Coordinate expression of vesicular acetylcholine transporter and choline acetyltransferase in sympathetic superior cervical neurons, Neuroreport 6, 965-968.
44. Misawa, H., Matsuura, J., Oda, Y., et al. (1997). Human choline acetyltransferase mRNAs with different 5′-region produce a 69-kDa major translation product, Mol. Brain Res. 44, 323-333.
45. Oda, Y., Nakanishi, I. and Deguchi, T. (1992). A complementary DNA for human choline acetyltransferase induces two forms of enzyme with different molecular weights in cultured cells, Mol. Brain Res. 16, 287-294.
46. Ogawa, H., Fujii, T., Watanabe, Y., et al. (2003). Expression of multiple species for choline acetyltransferase mRNA in human T-lymphocytes, Life Sci. 72, 2127-2130.
47. Okuda, T. and Haga, T. (2000). Functional characterization of the human high-affinity choline transporter, FEBS Lett. 484, 92-97.
48. Okuda, T., Haga, T., Kanai, Y., et al. (2000). Identification and characterization of the high-affinity choline transporter, Nat. Neurosci. 3, 120-125.
49. Okuma, Y. and Nomura, Y. (2001). Roles of muscarinic acetylcholine receptors in interleukin-2 synthesis in lymphocytes, Jpn. J. Pharmacol. 85, 16-19.
50. Oosawa, H., Fujii, T. and Kawashima, K. (1999). Nerve growth factor increases the synthesis and release of acetylcholine and the expression of vesicular acetylcholine transporter in primary cultured rat embryonic septal cells, J. Neurosci. Res. 57, 381-387.
51. Paldi-Haris, P., Szelenyi, J. G., Nguyen, T. H., et al. (1990). Changes in the expression of the cholinergic structures of human T lymphocytes due to maturation and stimulation, Thymus 16, 119-122.
52. Passweg, J., Thiel, G. and Bock, H. A. (1996). Monoclonal gammopathy after intense induction immunosuppression in renal transplant patients, Nephrol. Dial. Transplant. 11, 2461-2465.
53. Rinner, I. and Schauenstein, K. (1991). The parasympathetic nervous system takes part in the immunoneuroendocrine dialogue, J. Neuroimmunol. 34, 165-172.
54. Rinner, I. and Schauenstein, K. (1993). Detection of choline-acetyltransferase activity in lymphocytes, J. Neurosci. Res. 35, 188-191.
55. Rinner, I., Kawashima, K. and Schauenstein, K. (1998). Rat lymphocytes produce and secrete acetylcholine in dependence of differentiation and activation, J. Neuroimmunol. 81, 31-37.
56. Sakuragawa, N., Elwan, M. A., Uchida, S., et al. (2001). Non-neuronal neurotransmitters and neurotrophic factors in amniotic epithelial cells: expression and function in humans and monkey, Jpn. J. Pharmacol. 85, 20-23.
57. Sato, K. Z., Fujii, T., Watanabe, Y., et al. (1999). Diversity of mRNA expression for muscarinic acetylcholine receptor subtypes and neuronal nicotinic acetylcholine receptor subunits in human mononuclear leukocytes and leukemic cell lines, Neurosci. Lett. 266, 17-20.
58. Takeichi, N. (1995). Age-related immunological disorders in an animal model for hypertension, SHR rats, in: Progress in Hypertension, Vol. 3, New Advances in SHR Research: Pathology and Harmacology, Saito, H. and Yamori, Y., Minami, M. and Parvez, S. H. (Eds), pp. 33-43. VSP, Utrecht.
59. Takeichi, N., Hamada, J., Takimoto, M., et al. (1988). Depression of T cell-mediated immunity and enhancement of autoantibody production by natural infection with microorganisms in spontaneously hypertensive rats (SHR), Microbiol. Immunol. 32, 1235-1244.
60. Toyabe, S., Iiai, T., Fukuda, M., et al. (1997). Identification of nicotinic acetylcholine receptors in lymphocytes in the periphery as well as thymus in mice, Immunology 92, 201-205.
61. Tucek, S. (1988). Choline acetyltransferase and the synthesis of acetylcholine, in: Handbook of Experimental Pharmacology, The Cholinergic Synapse, Whittaker, V. P. (Ed.), Vol. 86, pp. 125-165. Springer Verlag, Berlin.
62. Ushiyama, N., Fujii, T. and Kawashima, K. (2001). A transient increase of intracellular free calcium ion concentration and up-regulation of alpha7 nicotinic acetylcholine receptor subunit gene expression by nicotine in CEM, a human leukemic T-cell line, Jpn. J. Pharmacol. 85 (Suppl.), 127P.
63. Watanabe, H., Garnier, G., Circolo, A., et al. (2000). Modulation of renal disease in MRL/lpr mice genetically deficient in the alternative complement pathway factor, Br. J. Immunol. 164, 786-794.
64. Wessler, I., Kirkpatrick, C. J. and Racké, K. (1998). Non-neuronal acetylcholine, a locally acting molecule widely distributed in biological system: expression and function in humans, Pharmacol. Ther. 77, 59-79.
65. Wessler, I., Kirkpatrick, C. J. and Racké, K. (1999). The cholinergic 'pitfall': acetylcholine, a universal cell molecule in biological systems including humans, Clin. Exp. Pharmacol. Physiol. 26, 198-205.
66. Wessler, I., Kilbinger, H., Bittinger, F., et al. (2001). The biological role of non-neuronal acetylcholine in plants and humans, Jpn. J. Pharmacol. 85, 2-10.
67. Yamada, S., Fujii, T. and Kawashima, K. (1997). Oral administration of KW-5092, a novel gastroprokinetic agent with acetylcholinesterase inhibitory and acetylcholine release enhancing activities, causes a dose-dependent increase in the blood acetylcholine content of beagle dogs, Neurosci. Lett. 225, 25-28.